Evidence map›Paper›PMID 40672510›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Structure-Function Correlation Using a Targeted Image- Guided Microperimetry Approach for Retinal Atrophic Diseases: A Methods Study.

Rubbia Afridi, M Sohail Halim, Mohamed Ahmed, Hikmet Yucel, Zoha Zahid Fazal, Kholood Janjua, Mauro Campigotto, Syed Mahmood Shah, Quan Dong Nguyen, Yasir Jamal Sepah

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Rubbia Afridi
M Sohail Halim
Mohamed Ahmed
Hikmet Yucel
Zoha Zahid Fazal
Kholood Janjua
Mauro Campigotto
Syed Mahmood Shah
Quan Dong Nguyen
Yasir Jamal Sepah

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: This proof-of-concept aimed to evaluate the feasibility of targeted, image-guided microperimetry (IGMP) by integrating Optical Coherence Tomography (OCT) and Fundus Autofluorescence (FAF) for lesion mapping and functional assessment in retinal atrophic diseases. Methods: 22 eyes were identified, of which 17 had early geographic atrophy (GA) while 5 had Stargardt Disease (SD). Disease transition zones (TZs) on OCT and FAF were annotated onto enface infrared images. These were then exported with microperimetry assessments to custom MATLAB applications. IGMP patterns were thereafter created and imported using MAIA and Nidek microperimeters for subsequent scans. Mean procedure and examination times (mins), retinal sensitivity (dB), approach feasibility, and algorithm compatibility of targeted IGMP were reported as outcomes. Results: Targeted IGMP was quicker than the standard 10-2 grid for both SD and GA lesion assessments. SD cases showed longer mean procedure and examination times and lower mean retinal sensitivity in all zones compared to GA lesions. Targeted IGMP procedure was lengthier for Nidek (29.2±7.1 mins) than MAIA (17.4±4.3 mins) although examination took longer on MAIA (4.0±1.0 mins) than on Nidek (3.6±1.2 mins). Overall, IGMP approach is feasible (100.0%) and the algorithm is compatible (100.0%) on both MP devices for all subjects tested. Conclusions: This study establishes the feasibility of an IGMP workflow in providing targeted functional assessments in retinal degenerative diseases. Our approach may help enhance structure- function correlation and optimize the efficiency of microperimetry integration for clinical trials. Further validation in larger cohorts is needed to assess its broader clinical applicability.

Identifiers

PMID40672510
PMCPMC12265736

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.